Review of the value of huperzine as pretreatment of organophosphate poisoning

NeuroToxicology

Volumn 23, Issue 1, 2002, Pages 1-5

  Lallement, Guy ^a   Baille, Valérie ^a   Baubichon, Dominique ^a   Carpentier, Pierre ^a   Collombet, Jean Marc ^a   Filliat, Pierre ^a   Foquin, Annie ^a   Four, Elise ^a   Masqueliez, Catherine ^a   Testylier, Guy ^a   Tonduli, Laura ^a   Dorandeu, Frédéric ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Huperzine; Organophosphate poisoning; Pyridostigmine

Indexed keywords

ACETYLCHOLINE; ATROPINE; ATROPINE METHYL NITRATE; BENZODIAZEPINE; BRAIN ENZYME; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DIAZEPAM; ERYTHROCYTE ENZYME; HUPERZINE A; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORGANOPHOSPHATE; OXIME; PHYSOSTIGMINE; PYRIDOSTIGMINE; SCAVENGER; SCOPOLAMINE; SOMAN; CHEMICAL WARFARE AGENT; ORGANOPHOSPHORUS COMPOUND; SESQUITERPENE;

ACETYLCHOLINE BRAIN LEVEL; ALZHEIMER DISEASE; ANTICONVULSANT ACTIVITY; BLOOD BRAIN BARRIER; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; COMPARATIVE TOXICOLOGY; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; GUINEA PIG; HUMAN; LD 50; LOW DRUG DOSE; MEMORY DISORDER; MYASTHENIA GRAVIS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; TREATMENT FAILURE; ANIMAL;

ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; SESQUITERPENES;

EID: 0036562617     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00015-3     Document Type: Review

References (28)

1. Ashani Y, Peggins J, Doctor B. Mechanism of inhibition of cholinesterases by huperzine. A Biochem Biophys Res Com 1992;30:719-26.
2. Ashani Y, Grundwald J, Alkalai D, Cohen G, Raveh L, Studies with Huperzine A, a new candidate in the research of prophylaxis against nerve agent. In: Proceedings of Medical Defence Bioscience Review, 1996. p. 105-110.
3. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. Pharmacol Exp Ther 1991;259:633-8.
4. Cohen SD. Carboxylesterase inhibition and potentiation of soman toxicity. Arch Toxicol 1981;49:105-6.
5. De Sarno P, Giacobini E. Modulation of acetylcholine release by nicotinic receptors in the rat brain. J Neurosci Res 1989;22:194-200.
6. Dirnhuber P, French C, Green M, Leadbeater L, Stratton A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharmacol 1979;1:295-9.
7. Filliat P, Foquin A, Lallement G, Effects of chronic administration of Huperzine A on memory in guinea-pigs, Drug Chem Toxicol 2002, in press.
8. Fosbraey P, Wetherell JR, French MC. Effect of acute physostigmine-hyoscine pretreatment on the neurochemical changes produced by soman in the guinea-pig. Neurochem Int 1991;18:265-73.
9. Gordon J, Leadbeater L, Maidment P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 1978;43:207-16.
10. Grunwald J, Raveh L, Doctor P, Ashani Y. Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 1994;54:991-7.
11. Hale S, Ved H, Doctor WB, Tortella F, EEG evaluation of Huperzine A, a potential pretreatment for nerve agent intoxication. In: Proceedings of the Medical Defence Bioscience Review 2000, p. 77
12. Koplovitz I, Gresham V, Kaminski A, Stewart J, Evaluation of the toxicity and treatment of GF poisoning in Rhesus monkeys, In: Proceedings of the NATO RSG 3 Panel VIII, 1991. p. 632-43
13. Lallement G, Veyret J, Masqueliez M, Aubriot S, Burckhart MF, Baubichon D. Efficacy of huperzine in preventing somaninduced seizures, neuropathological changes and lethality. Fund Clin Pharmacol 1997;11:387-94.
14. Lallement G, Foquin A, Dorandeu F, Baubichon D, Carpentier P. Subchronic administration of various pretreatments of nerve agent poisoning-part I: protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. Drug Chem Toxicol 2001a;24:151-64.
15. Lallement G, Foquin A, Dorandeu F, Baubichon D, Aubriot S, Carpentier P. Subchronic administration of various pretreatments of nerve agent poisoning-part II: compared efficacy against soman toxicity. Drug Chem Toxicol 2001;24:165-80.
16. Lallement G, Demoncheaux JP, Foquin A, Baubichon D, Galonnier M, Clarencon D, Dorandeu F, Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity, Drug Chem Toxicol 2002, in press.
17. Lemercier G, Carpentier P, Sentenac-Roumanou H, Morélis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol 1983;61:123-9.
18. Lim DK, Ito Y, Yu ZJ, Hoskins B, Ho IK. Prevention of soman toxicity after the continuous administration of physostigmine. Pharmacol Biochem Behav 1989;31:633-9.
19. Matthew CB. Anticholinergics: effects on thermoregulation and performance in rats. Neurosci Biobehav Rev 1991;15:141-6.
20. Philippens I, Wolthuis O, Busker R, Langenberg P, Melchers C. Side effects of physostigmine as a pretreatment in guinea-pigs. Pharmacol Biochem Behav 1996;55:99-105.
21. Philippens I, Busker R, Wolthuis WL, Olivier B, Bruijnzeel PLB, Melchers C. Subchronic physostigmine pretreatment in guinea-pigs: effective against soman and without side effect. Pharmacol Biochem Behav 1997;59:1061-7.
22. Philippens I, Melchers BPC, Olivier B, Bruijnzeel PLB. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea-pigs. Pharmacol Biochem Behav 2000;65:175-82.
23. Pilotaz F, Masson P. L'huperzine A: un inhibiteur de l'acétylcholinestérase à fort potentiel pharmacologique. Ann Pharm Fr 1999;57:363-73.
24. Powell RJ, Winkler H. Nicotinic stimulation of 3H-acetylcholine release from mouse cerebral cortex synaptosomes. J Neurochem 1984;43:1593-8.
25. Tang X, De-Sarno P, Sugaya K, Giacobini E. Effect of Huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res 1989;24:276-85.
26. Tonduli L, Testylier G, Masqueliez C, Lallement G, Monmaur P. Effects of huperzine used as pretreatment against soman-induced seizures. NeuroToxicology 2001;22:29-7.
27. Ved HS, Koenig ML, Dave JR, Doctor BP. Huperzine A a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuro Rep 1997;8:963-8.
28. Wetherell J. Continuous administrations of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacition produced by soman poisoning. J Pharm Pharmacol 1994;71:1023-8.